Selecting the optimal media for a specific cell line’s growth can be a challenging task, partly due to the quantity of catalog and custom options available. By having clear goals mapped out and identifying key parameters affecting critical quality attributes (CQA) earlier on, one can accelerate the path to market. This on-demand webinar reviews best practices using a media panel approach to reduce timelines and increase productivity.
Gain insight into how practical implementation of innovative technologies and solutions such as multi-attribute method, modernized cell line development workflow using high-yield cell lines and automated systems, as well as next generation purification resins help to accelerate biologics development and commercialization.
Early viral vector process development for cell and gene therapies is critical to assure a production strategy that supports commercial needs. In this webinar, you will learn the importance of planning for scalability and manufacturability from the earliest stages of process development and how a scalable templated process can reduce time needed to move from product development to commercialization.
Is viral clearance a hurdle to implementing continuous processing? In this webinar, we will share virus spiking alternatives that may pave the way for effectively evaluating viral clearance by chromatography steps in a continuous process.
In this webinar, we demonstrate, how different process parameter can be monitored and controlled in a perfusion bioprocess to cultivate anchorage-dependent cells. We demonstrate the great potential of using packed-bed bioreactors or microcarrier spin filter for attachment cell-based vaccine production.
The Covid-19 pandemic lead to a strong increase of vaccine development projects and new vaccine manufacturing approaches. In this panel discussion, experts from Eppendorf and ContiVir share their thoughts on how they are “rethinking vaccine development”.
Due to the current Covid-19 pandemic, vaccines and vaccine development are frequently discussed topics. Listen to the talk of Dr. Jörg Schwinde, explaining everything you need to know about viruses, vaccines and vaccine development.
This presentation addresses keys to outsourced drug production, including the importance of seeking the right partnerships to help overcome the challenges associated with secure commercial product supply.
Expediting development timeline is directly related to obtaining IND clearance and starting phase 1 study faster. This webinar describes how you can get to IND faster through our accelerated & high performance proprietary cell line. We will present our 3 month cell line development timeline and high quality cell line with outstanding productivity. We hope to share how our Faster & Better approach, which can be applicable to your molecule's successful development path to IND.
The webinar recording reviews an application of alkali stable protein A for the purification of fragment antibody molecules. It will cover the binding mechanism between the engineered C domain of the Amsphere™ A3 protein A (PrA) ligand and a VHH single-domain antibody (sdAb), Protein A – Ab fragment complex structure via x-ray crystallography and CH1 binding capacity and purification case study results.